. Author manuscript; available in PMC: 2013 Mar 12.

Published in final edited form as: JACC Cardiovasc Imaging. 2011 Dec;4(12):1231–1238. doi: 10.1016/j.jcmg.2011.09.012

Table 1.

Baseline Characteristics of Patients With HIV Cardiomyopathy

Age, yrs	54 ± 9
Male	45 (75)
Hypertension	36 (60)
Diabetes mellitus	11 (18)
Dyslipidemia	21 (35)
NYHA functional class
I	5 (8)
II	25 (42)
III	22 (37)
IV	8 (13)
Hemodynamic variables
Resting SBP, mm Hg	128 ± 16
Resting DBP, mm Hg	80 ± 12
Resting heart rate, beats/min	81 ± 12
Echocardiographic variables
Left atrial dimension index, cm/m²	2.40 ± 0.43
LVEDVI, ml/m²	82 ± 17
LVESVI, ml/m²	60 ± 20
LVEF, %	28 ± 11
Resting LV WMSI	2.59 ± 0.57
Resting RV WMSI	1.58 ± 0.80
ΔWMSI	0.79 ± 0.53
Medications
Beta-blocker	44 (73)
ACE-I or ARB	40 (67)
Diuretics	27 (45)
HIV-associated factors
CD4 count, cell/mm³	243 (86/348)
Viral load copies/ml	1,240 (<50/36,109)
AIDS diagnosis	35 (58)
Duration of HIV infection, yrs	11 ± 6
Antiretroviral therapy	46 (77)

Values are mean ± SD, n (%), or median (25th/75th percentile).

ACE-I = angiotensin-converting enzyme inhibitor; AIDS = acquired immunodeficiency syndrome; ARB = angiotensin II receptor blocker; DBP = diastolic blood pressure; HIV = human immunodeficiency virus; LV = left ventricular; LVEDVI = left ventricular end-diastolic volume index; LVEF = left ventricular ejection fraction; LVESVI = left ventricular end-systolic volume index; NYHA = New York Heart Association; RV = right ventricular; SBP = systolic blood pressure; WMSI = wall motion score index.